Baidu
map

NAMS 2016:如何提高女性的性满意度?

2016-10-06 Mechront 译 MedSci原创

近期北美更年期学会的年度会议上有数据显示:女性只要改变对性行为的期望,或改变性优先级,就可以改善或维持整体的性满意度。 来自匹兹堡大学的Holly N. Thomas博士和同事们对39名女性进行了研究,平均年龄58岁,评估其性功能方面的认知功能改变,调查她们如何应对这些变化。 总体而言,13%的参与者没有绝经,44%的参与者处于例围绝经期,还有28%的参与者不清楚当前时期。 最常

近期北美更年期学会的年度会议上有数据显示:女性只要改变对性行为的期望,或改变性优先级,就可以改善或维持整体的性满意度。

来自匹兹堡大学的Holly N. Thomas博士和同事们对39名女性进行了研究,平均年龄58岁,评估其性功能方面的认知功能改变,调查她们如何应对这些变化。

总体而言,13%的参与者没有绝经,44%的参与者处于例围绝经期,还有28%的参与者不清楚当前时期。

最常见的负面变化是频率下降、性欲降低、阴道干燥和难以达到性高潮;这些变化更多的归因于心理压力,而不是生物因素。负性变化的主要来源也包括性伴侣,包括性伴侣的健康问题、与性伴侣的关系不和谐、以及性伴侣的性功能障碍。

最常见的积极变化是增加性满意度,尽管性活动频率在下降。之所以会有积极变化,可能与更高程度的自信、自我认识的增加、以及更好的沟通技巧有关。

对消极变化的反应是冷漠、痛苦和适应。适应方面包括使用阴道润滑剂、延长前戏、尝试其他性行为、自慰、鼓励性伴侣、治疗勃起功能障碍等。

研究者称:这一系列变化中,心理社会和人际因素起着重要的作用,包括伴侣性功能障碍。有必要对中年女性性功能的正面和负面变化做进一步研究。

原始出处:


Thomas HN, et al. S-13. Presented at: Annual Meeting of the North American Menopause Society; Oct. 5-8, 2016; Orlando, Fla.

Women’s sexual satisfaction increases with changing attitudes.Healio.October 5, 2016

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1988160, encodeId=200b1988160ba, content=<a href='/topic/show?id=10195268240' target=_blank style='color:#2F92EE;'>#性满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52682, encryptionId=10195268240, topicName=性满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Sun Aug 20 22:16:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160744, encodeId=0b55160e440c, content=赞同?,希望继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Dec 06 20:14:34 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478639, encodeId=d05314e8639c0, content=<a href='/topic/show?id=d561665e7af' target=_blank style='color:#2F92EE;'>#满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66577, encryptionId=d561665e7af, topicName=满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1627448984, createdName=ms1692212821629096, createdTime=Sat Oct 08 04:16:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141389, encodeId=a618141389e8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:39 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141388, encodeId=446514138871, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:31 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141107, encodeId=763614110eb4, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwpiauGyBL4m0bkMMStxcjA3iaoT6JAG8Sv5iaHXYJUI6Zvfias3FZjXPxoJSoH6g2ZAeJhibC42aYNpz/0, createdBy=6b0c1735343, createdName=李医生wxsession0e3ca46b, createdTime=Thu Oct 06 14:48:55 CST 2016, time=2016-10-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1988160, encodeId=200b1988160ba, content=<a href='/topic/show?id=10195268240' target=_blank style='color:#2F92EE;'>#性满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52682, encryptionId=10195268240, topicName=性满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Sun Aug 20 22:16:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160744, encodeId=0b55160e440c, content=赞同?,希望继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Dec 06 20:14:34 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478639, encodeId=d05314e8639c0, content=<a href='/topic/show?id=d561665e7af' target=_blank style='color:#2F92EE;'>#满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66577, encryptionId=d561665e7af, topicName=满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1627448984, createdName=ms1692212821629096, createdTime=Sat Oct 08 04:16:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141389, encodeId=a618141389e8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:39 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141388, encodeId=446514138871, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:31 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141107, encodeId=763614110eb4, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwpiauGyBL4m0bkMMStxcjA3iaoT6JAG8Sv5iaHXYJUI6Zvfias3FZjXPxoJSoH6g2ZAeJhibC42aYNpz/0, createdBy=6b0c1735343, createdName=李医生wxsession0e3ca46b, createdTime=Thu Oct 06 14:48:55 CST 2016, time=2016-10-06, status=1, ipAttribution=)]
    2016-12-06 明崖

    赞同?,希望继续努力

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1988160, encodeId=200b1988160ba, content=<a href='/topic/show?id=10195268240' target=_blank style='color:#2F92EE;'>#性满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52682, encryptionId=10195268240, topicName=性满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Sun Aug 20 22:16:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160744, encodeId=0b55160e440c, content=赞同?,希望继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Dec 06 20:14:34 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478639, encodeId=d05314e8639c0, content=<a href='/topic/show?id=d561665e7af' target=_blank style='color:#2F92EE;'>#满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66577, encryptionId=d561665e7af, topicName=满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1627448984, createdName=ms1692212821629096, createdTime=Sat Oct 08 04:16:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141389, encodeId=a618141389e8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:39 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141388, encodeId=446514138871, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:31 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141107, encodeId=763614110eb4, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwpiauGyBL4m0bkMMStxcjA3iaoT6JAG8Sv5iaHXYJUI6Zvfias3FZjXPxoJSoH6g2ZAeJhibC42aYNpz/0, createdBy=6b0c1735343, createdName=李医生wxsession0e3ca46b, createdTime=Thu Oct 06 14:48:55 CST 2016, time=2016-10-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1988160, encodeId=200b1988160ba, content=<a href='/topic/show?id=10195268240' target=_blank style='color:#2F92EE;'>#性满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52682, encryptionId=10195268240, topicName=性满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Sun Aug 20 22:16:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160744, encodeId=0b55160e440c, content=赞同?,希望继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Dec 06 20:14:34 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478639, encodeId=d05314e8639c0, content=<a href='/topic/show?id=d561665e7af' target=_blank style='color:#2F92EE;'>#满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66577, encryptionId=d561665e7af, topicName=满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1627448984, createdName=ms1692212821629096, createdTime=Sat Oct 08 04:16:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141389, encodeId=a618141389e8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:39 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141388, encodeId=446514138871, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:31 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141107, encodeId=763614110eb4, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwpiauGyBL4m0bkMMStxcjA3iaoT6JAG8Sv5iaHXYJUI6Zvfias3FZjXPxoJSoH6g2ZAeJhibC42aYNpz/0, createdBy=6b0c1735343, createdName=李医生wxsession0e3ca46b, createdTime=Thu Oct 06 14:48:55 CST 2016, time=2016-10-06, status=1, ipAttribution=)]
    2016-10-07 知难而进

    继续关注!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1988160, encodeId=200b1988160ba, content=<a href='/topic/show?id=10195268240' target=_blank style='color:#2F92EE;'>#性满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52682, encryptionId=10195268240, topicName=性满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Sun Aug 20 22:16:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160744, encodeId=0b55160e440c, content=赞同?,希望继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Dec 06 20:14:34 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478639, encodeId=d05314e8639c0, content=<a href='/topic/show?id=d561665e7af' target=_blank style='color:#2F92EE;'>#满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66577, encryptionId=d561665e7af, topicName=满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1627448984, createdName=ms1692212821629096, createdTime=Sat Oct 08 04:16:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141389, encodeId=a618141389e8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:39 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141388, encodeId=446514138871, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:31 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141107, encodeId=763614110eb4, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwpiauGyBL4m0bkMMStxcjA3iaoT6JAG8Sv5iaHXYJUI6Zvfias3FZjXPxoJSoH6g2ZAeJhibC42aYNpz/0, createdBy=6b0c1735343, createdName=李医生wxsession0e3ca46b, createdTime=Thu Oct 06 14:48:55 CST 2016, time=2016-10-06, status=1, ipAttribution=)]
    2016-10-07 知难而进

    谢谢分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1988160, encodeId=200b1988160ba, content=<a href='/topic/show?id=10195268240' target=_blank style='color:#2F92EE;'>#性满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52682, encryptionId=10195268240, topicName=性满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84fb152, createdName=xiongliangxl, createdTime=Sun Aug 20 22:16:00 CST 2017, time=2017-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=160744, encodeId=0b55160e440c, content=赞同?,希望继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Dec 06 20:14:34 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478639, encodeId=d05314e8639c0, content=<a href='/topic/show?id=d561665e7af' target=_blank style='color:#2F92EE;'>#满意度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66577, encryptionId=d561665e7af, topicName=满意度)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1627448984, createdName=ms1692212821629096, createdTime=Sat Oct 08 04:16:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141389, encodeId=a618141389e8, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:39 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141388, encodeId=446514138871, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Fri Oct 07 07:29:31 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141107, encodeId=763614110eb4, content=赞同, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KwpiauGyBL4m0bkMMStxcjA3iaoT6JAG8Sv5iaHXYJUI6Zvfias3FZjXPxoJSoH6g2ZAeJhibC42aYNpz/0, createdBy=6b0c1735343, createdName=李医生wxsession0e3ca46b, createdTime=Thu Oct 06 14:48:55 CST 2016, time=2016-10-06, status=1, ipAttribution=)]
    2016-10-06 李医生wxsession0e3ca46b

    赞同

    0

相关资讯

ACNC 2016:女性截肢者还需要更多的关注和研究

截肢者联盟国家会议上称,虽然有研究显示女性截肢者在康复、假肢部件和截肢的心理影响等方面有独特需求,但是还需要更多的研究来探究男性和女性截肢方式差异。美国肢体创伤截肢中心的Billie J. Randolph博士和Andrea Crunkhorn博士称,目前大多数假体等都是针对男性截肢者。Crunkhorn报道说,2005年25%的截肢患者是女性。45%的截肢原因为外伤,19%是女性。此外,有15%

为什么男性比女性更容易感觉热?

已有研究证明,女性常常体温偏寒而男性偏热。为什么男性比女性更容易感觉热?本文从身体脂肪到荷尔蒙分泌等方面分析了导致两性体温差异的原因。据悉,由于较小的身体和较慢的新陈代谢,女性散热更容易;而男性拥有更多可以保温的肌肉更容易感觉热。不过女性在妊娠期为保护胎儿也拥有更好的热量储备。总而言之,女性的体温会受其荷尔蒙分泌情况而发生改变。现实生活中,丈夫睡觉感到热时便一脚踢掉羽绒被;而妻子不仅躲在被窝里,甚

BMJ:女性偏头痛增加了心血管疾病事件的风险

该研究的目的是评估女性偏头痛和心血管疾病事件和心血管疾病的死亡率之间的关联。原始出处:Tobias Kurth,Anke C Winter,A Heather Eliassen,et al.Migraine and risk of cardiovascular disease in women,BMJ,2016.6.1

SLEEP 2016:女性退伍军人的失眠症状十分常见

根据SLEEP 2016年度会议上的数据显示,失眠症状在女性退伍军人中普遍存在,而且相比其他精神健康症状,是最常见的。为了评估女性退伍军人失眠症状的患病率,研究人员使用退伍军人初级保健数据进行了一个分层随机抽样的横截面分析(n = 6,247)。总体而言,47.5%的队列参与者失眠症状筛查时结果阳性,一小部分人是睡眠障碍(0.27%)。分析表明,那些有失眠与没有失眠的人相比,门诊心理健康访问存在差

Br J Surg:应对65岁女性进行腹主动脉瘤筛查

背景:四个65-80岁的男性随机对照试验表明:通过超声筛查,动脉瘤相关的死亡率可减少40%。腹主动脉瘤(AAA)的患病率是1.0%或更高时,超声检查是有可观的经济效益的。但女性患者AAA发病率小于1.0%。本研究的目的是超声扫描确定女性3.0 cm或更大AAA的发生率,这类人群中AAA相关危险因素,是否可以确定为1%或更高的AAA发生率的高危患者。方法:收集英国私人心血管检查的50000名女性的人

Clin Nutr:健康超重女性的循环酰基肉碱研究

不管是啮齿类动物还是人类,循环酰基肉碱(acyl-CNTs)与胰岛素抵抗(IR)和2型糖尿病(T2DM)有关。不过,这些条件下,循环acyl-CNTs增加的背后机制是什么?它们对全身新城代谢又有什么作用?本研究的目的是确定人类血细胞对循环acyl-CNTs产生的贡献,以及循环acyl-CNTs和全身脂肪代谢之间的关系。 研究纳入了8例非糖尿病健康妇女(年龄:47±19岁;体重指数:26 ±

Baidu
map
Baidu
map
Baidu
map